ArticlePharmaceutics2025

Selection of In Vivo Relevant Dissolution Test Parameters for the Development of Cannabidiol Formulations with Enhanced Oral Bioavailability.

Nathan Koch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.